ArticleBritish journal of clinical pharmacology2015

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.

Yosuke Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.